We are live on ! Find out more
QT

Quantbot Technologies Portfolio holdings

AUM $2.44B
1-Year Est. Return 17.13%
This Fund
S&P 500
This Quarter Est. Return
+2.49%
1 Year Est. Return
+17.13%
3 Year Est. Return
+22.15%
5 Year Est. Return
-1.03%
10 Year Est. Return
+28.04%
AUM
$1.23B
AUM Growth
-$134M
Cap. Flow
-$134M
Cap. Flow %
-10.84%
Top 10 Hldgs %
7.8%
Holding
2,092
New
622
Increased
370
Reduced
432
Closed
643

Top Buys

Rank Stock Value
1
IP icon
International Paper
IP
+$11.4M
2
ABNB icon
Airbnb
ABNB
+$11.1M
3
MCO icon
Moody's
MCO
+$8.18M
4
NET icon
Cloudflare
NET
+$8.15M
5
VZ icon
Verizon
VZ
+$7.83M

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$14.1M
2
UNP icon
Union Pacific
UNP
+$13.2M
3
MS icon
Morgan Stanley
MS
+$10.8M
4
OTIS icon
Otis Worldwide
OTIS
+$10M
5
UNH icon
UnitedHealth
UNH
+$9.98M

Sector Composition

Rank Sector Weight
1 Technology 17.38%
2 Financials 13.18%
3 Consumer Discretionary 12.42%
4 Industrials 12.36%
5 Healthcare 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTRS
1426
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
$2K ﹤0.01%
+342
New +$2.96K
CTT
1427
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$2K ﹤0.01%
+264
New +$2.35K
BANC icon
1428
Banc of California
BANC
$3.3B
$1K ﹤0.01%
+100
New +$2.02K
LZB icon
1429
La-Z-Boy
LZB
$1.55B
$1K ﹤0.01%
28
-162
-85% -$5.65K
QNCX icon
1430
Quince Therapeutics
QNCX
$17.9M
$1K ﹤0.01%
1
-1
-50% -$6.1K
SMRT icon
1431
SmartRent
SMRT
$183M
$1K ﹤0.01%
+153
New +$1.74K
TXMD icon
1432
TherapeuticsMD
TXMD
$23.8M
$1K ﹤0.01%
64
MORF
1433
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1K ﹤0.01%
36
-800
-96% -$42.9K
SWI
1434
DELISTED
SolarWinds Corporation Common Stock
SWI
$1K ﹤0.01%
+100
New +$1.62K
BHVN
1435
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1K ﹤0.01%
+10
New +$1.27K
AA icon
1436
Alcoa
AA
$11.9B
-63,364
Closed -$3.1M
ABBV icon
1437
AbbVie
ABBV
$454B
-10,504
Closed -$1.13M
ABCB icon
1438
Ameris Bancorp
ABCB
$6B
-1,321
Closed -$68K
ABT icon
1439
Abbott
ABT
$175B
-119,340
Closed -$14.1M
ABTS icon
1440
Abits Group
ABTS
$3.61M
-88
Closed -$10K
ACA icon
1441
Arcosa
ACA
$7.13B
-2,600
Closed -$130K
ACAD icon
1442
Acadia Pharmaceuticals
ACAD
$4.25B
-12,100
Closed -$200K
ACIW icon
1443
ACI Worldwide
ACIW
$5.54B
-5,469
Closed -$168K
ACN icon
1444
Accenture
ACN
$84.9B
-26,588
Closed -$8.51M
ACRS icon
1445
Aclaris Therapeutics
ACRS
$765M
-765
Closed -$13K
ADBE icon
1446
Adobe
ADBE
$84.3B
-10,459
Closed -$6.02M
ADC icon
1447
Agree Realty
ADC
$9.59B
-179
Closed -$11K
ADEA icon
1448
Adeia
ADEA
$2.97B
-3,890
Closed -$19K
AEIS icon
1449
Advanced Energy
AEIS
$12.6B
-5,861
Closed -$514K
AEM icon
1450
Agnico Eagle Mines
AEM
$72.3B
-11,649
Closed -$604K

Similar funds

Quantbot Technologies's Q4 2021 Portfolio in Review

As of Q4 2021, Quantbot Technologies held 2,092 positions worth $1.23B, down 9.8% from $1.37B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Quantbot Technologies withdrew a net $134M in Q4 2021, closing 643 positions and reducing 432 holdings. Its most notable exit was Abbott, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Quantbot Technologies opened a new position in International Paper worth $10.9M.

  • Quantbot Technologies's largest Q4 2021 buy was International Paper: 231,024 shares worth $10.9M.
  • Quantbot Technologies added most to Airbnb in Q4 2021, an estimated $11.1M increase.
  • Quantbot Technologies's biggest Q4 2021 reduction was Capital One, cutting an estimated $8.85M.
  • Quantbot Technologies fully exited Abbott in Q4 2021, selling an estimated $14.1M.
  • Quantbot Technologies's ten largest holdings make up 7.8% of its $1.23B portfolio in Q4 2021.
  • Quantbot Technologies opened 622 new positions and closed 643 in Q4 2021.
  • Quantbot Technologies's portfolio value fell 9.8% quarter-over-quarter to $1.23B.

Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.